Inimmune Presents Late-Breaking Phase 1 INI-4001 Results Demonstrating On-Target Immune Activation in Advanced Solid Tumors at SITC 2026

The Quick Take
Study demonstrated no dose-limiting toxicities and dose-responsive cytokine production consistent with TLR7/8 engagement Results support continued clinical development of INI-4001 as a potential monotherapy and in combination with other cancer treatments MISSOULA, Mont., Nov. 6, 2026...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Introducing IAN: A New Longevity-Focused Wellness Company on a Mission to Put More Life Into Every Year
Debuting December 22, IAN brings foundational nutrition and longevity support together in one daily stack gummy WEST PALM BEACH, Fla., Nov. 6, 2026…
Business
Mazda da la bienvenida a la temporada con su evento anual de ventas de invierno e incentivos excepcionales para clientes
Concesionarios de todo el país ofrecen ahorros de hasta USD $3.000 en crossovers seleccionados hasta el 4 de enero de 2027 IRVINE, California, 6 de noviembre…
Business
In HelloNation, Moving Expert Mike Sheridan Outlines When to Hire Professional Packing Services Instead of Doing It Yourself
The Article Details How Time, Fragile Items, and Moving Timeline Help Households Decide Whether Packing Help Is the Right Choice. ROCHESTER, N.Y., Nov. 6, 2026…
Local
CALV Presents Nov. 13 “World of Commercial” Class for Local Real Estate Pros - Nevada Business Magazine
CALV Presents Nov. 13 “World of Commercial” Class for Local Real Estate Pros Nevada Business Magazine
